PSMA-PRED protocol plans biomarker search for lutetium-PSMA treatment response
The French PSMA-PRED protocol plans to profile tumor DNA, RNA and methylation in 120 patients to identify candidate biomarkers associated ...
The French PSMA-PRED protocol plans to profile tumor DNA, RNA and methylation in 120 patients to identify candidate biomarkers associated ...
A patient-specific whole-genome liquid biopsy detected lung cancer DNA associated with recurrence months before tumors became visible on imaging in ...
An exploratory BRIGHT-2 trial analysis associated longitudinal ctDNA patterns with prognosis, molecular response and candidate resistance alterations in advanced breast ...
A 2026 correspondence questions the robustness of reported links between neighborhood deprivation, metastatic breast cancer genomics, targeted treatment use and ...
A review evaluates circulating tumor DNA testing for detecting ESR1-mutant clones and organizing treatment sequencing in hormone receptor-positive, HER2-negative advanced ...
A new review outlines how drug-tolerant persister cells hidden within minimal residual disease drive cancer relapse and how pathway inhibitors, ...
A new review details how ESR1 mutations, bypass signaling, and cell-cycle escape drive endocrine resistance in the most common breast ...
The concept of grouping EGFR mutations by structural rather than purely positional criteria represents a meaningful shift in how oncologists ...
A new study shows that sequencing tumor DNA in ascites, pleural fluid, cerebrospinal fluid, and pericardial effusions can detect malignancies ...
A new review outlines how genetic risk profiling, new-onset diabetes screening, advanced imaging, liquid biopsy biomarkers and artificial intelligence are ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine